Asep Medical Confirms the Use of AI - Enables Improved Treatments for Common Biofilm Infections and Rapid Sepsis Diagnostics

VANCOUVER, BC, March 13, 2024 /CNW/ - In a recent presentation to the US Biophysical Society in Philadelphia¹, Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CNSX:ASEP.CN) (OTC-BB:SEPSF) (FSE:JJ8) CEO Dr. Bob Hancock announced how the ground-breaking use of artificial intelligence (AI) has allowed the development of new and improved treatments for biofilm infections.